© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
“The biggest risk that our patients face is a severe COVID-19 episode,” says Kutikov.
Alexander Kutikov, MD, discusses his experience with the COVID-19 vaccine and patients with genitourinary cancer. Kutikov is chief, Division of Urology and Urologic Oncology, professor, Department of Surgical Oncology, and Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center.
Related Content: